ClinicalTrials.Veeva

Menu

Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies. (MURIELLE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Prostate Cancer

Treatments

Procedure: systematic biopsies
Procedure: Targeted biopsies guided by a fusion of MRI and ultrasound- images

Study type

Interventional

Funder types

Other

Identifiers

NCT02050542
SC 3065 (Other Identifier)
2013-A00514-41

Details and patient eligibility

About

The purpose of the study is to show that 3 targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system, will get no lower rate of cancer detection than those obtained by 12 systematic transrectal ultrasound-guided biopsies of the prostate.

Full description

The act of current practice evaluated by this research is the act of prostate biopsies : the patient will have to undergo 12 systematized transrectal echography guided biopsies of the prostate and 3 additional biopsies targeted on the suspicious lesion detected with MRI, which are both done in current practice.

  • A first operator is not informed of the location of the target. He will perform a series of 12 systematic transrectal ultrasound-guided biopsies of the prostate.
  • Immediately after the second operator will perform 3 additional targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system

Act added by the research: Using a fusion of MRI - ultrasound images software system (Koelis ®).

Enrollment

108 patients

Sex

Male

Ages

45 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient from 45 to 75 years old;
  • Serum level of PSA > 4,0 ng / mL;
  • Multiparametric prostate IRM, performed before inclusion and which confirm the diagnosis of suspected target;
  • No opposition of the patient notified in the medical record
  • patient member in a national insurance scheme.

Exclusion criteria

  • Previous prostate biopsy;
  • suspicious digital rectal examination;
  • serum PSA > 20,0 ng / mL;
  • treatment with 5 alpha reductase inhibitor during the last 3 months;
  • untreated urinary infection

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

108 participants in 2 patient groups

Targeted biopsies guided by a fusion of MRI and ultrasound
Other group
Description:
After the 12 systematic biopsies, the same patients will have to undergo 3 additional targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system
Treatment:
Procedure: Targeted biopsies guided by a fusion of MRI and ultrasound- images
Procedure: systematic biopsies
Systematic biopsies
Other group
Description:
The patients will have to undergo 12 systematic transrectal ultrasound-guided biopsies of the prostate
Treatment:
Procedure: Targeted biopsies guided by a fusion of MRI and ultrasound- images
Procedure: systematic biopsies

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems